What does Apotheek Mannenberg do?

Apotheek Mannenberg is a pharmacy in Scherpenheuvel-Zichem. Public Limited, started on 26 May 1997, 1 establishment.

What is the address of Apotheek Mannenberg?

The registered office of Apotheek Mannenberg is located at Mannenberg(S) 23, 3270 Scherpenheuvel-Zichem.

Is Apotheek Mannenberg still active?

Yes. According to the CBE (30 October 2026) Apotheek Mannenberg is active, legal situation “Normale toestand”, started on 26 May 1997.

Is Apotheek Mannenberg registered on Peppol?

Yes, Apotheek Mannenberg is registered on the Peppol network with ID 0208:0460754255.

What is the enterprise number of Apotheek Mannenberg?

The enterprise number of Apotheek Mannenberg is BE0460754255.

When was Apotheek Mannenberg founded?

Apotheek Mannenberg was founded on 26 May 1997.

Who are the directors of Apotheek Mannenberg?

According to the 2025 annual accounts, the directors of Apotheek Mannenberg are: Daho BV.

Is Apotheek Mannenberg a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 May 1997; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Apotheek Mannenberg make in 2025?

Apotheek Mannenberg posted a profit after taxes of € 338,900 in financial year 2025.

What is the revenue of Apotheek Mannenberg?

As a small company, Apotheek Mannenberg is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 411,043.

Apotheek Mannenberg (Public Limited)

Dossier Apotheek Mannenberg, printed on 30 October 2026 from databakkes.be/en/0460754255/apotheek-mannenberg. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 54 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Apotheek Mannenberg from Scherpenheuvel-Zichem, company number BE0460754255, closed financial year 2025 with a result of € 338,900 after tax. For that financial year Apotheek Mannenberg recorded a gross margin of € 411,043 and equity of € 454,550. Compared with financial year 2024, the result moved from € 509,587 to € 338,900. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 454,550

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 338,900

▼ 33% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 357,183

▼ 47% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 335,000 paid out

99 % of the profit went to the shareholders, mostly to DAHO (100 % of the shares). That is where the money ends up.

People and assets in 2025

Vehicles and equipment

€ 2,228

▼ 13% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 10 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 850,987

▼ 9% vs 2024

€ 85,376 is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.

Owed to suppliers

€ 598,385

▲ 1% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 1,844

▼ 70% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 339,595 Gross margin 2022: € 339,595 First fiscal year in the series	€ 536,712 Gross margin 2023: € 536,712 ▲ 58% vs 2022 (€ 339,595) Favourable step	€ 583,910 Gross margin 2024: € 583,910 ▲ 9% vs 2023 (€ 536,712) Favourable step	€ 411,043 Gross margin 2025: € 411,043 ▼ 30% vs 2024 (€ 583,910) Unfavourable step	▼ 30%
Profit after taxes	€ 262,667 Profit after taxes 2022: € 262,667 First fiscal year in the series	€ 466,593 Profit after taxes 2023: € 466,593 ▲ 78% vs 2022 (€ 262,667) Favourable step	€ 509,587 Profit after taxes 2024: € 509,587 ▲ 9% vs 2023 (€ 466,593) Favourable step	€ 338,900 Profit after taxes 2025: € 338,900 ▼ 33% vs 2024 (€ 509,587) Unfavourable step	▼ 33%
Equity	€ 444,470 Equity 2022: € 444,470 First fiscal year in the series	€ 446,063 Equity 2023: € 446,063 Unchanged (€ 444,470) Favourable step	€ 450,650 Equity 2024: € 450,650 ▲ 1% vs 2023 (€ 446,063) Favourable step	€ 454,550 Equity 2025: € 454,550 ▲ 1% vs 2024 (€ 450,650) Favourable step	▲ 1%
Total debts	€ 1,634,407 Total debts 2022: € 1,634,407 First fiscal year in the series	€ 1,897,614 Total debts 2023: € 1,897,614 ▲ 16% vs 2022 (€ 1,634,407) Unfavourable step	€ 2,352,342 Total debts 2024: € 2,352,342 ▲ 24% vs 2023 (€ 1,897,614) Unfavourable step	€ 2,094,360 Total debts 2025: € 2,094,360 ▼ 11% vs 2024 (€ 2,352,342) Favourable step	▼ 11%
Cash	€ 156,726 Cash 2022: € 156,726 First fiscal year in the series	€ 308,482 Cash 2023: € 308,482 ▲ 97% vs 2022 (€ 156,726) Favourable step	€ 675,720 Cash 2024: € 675,720 ▲ 119% vs 2023 (€ 308,482) Favourable step	€ 357,183 Cash 2025: € 357,183 ▼ 47% vs 2024 (€ 675,720) Unfavourable step	▼ 47%
Land & buildings	€ 1,638,643 Land & buildings 2022: € 1,638,643 First fiscal year in the series	€ 1,619,158 Land & buildings 2023: € 1,619,158 ▼ 1% vs 2022 (€ 1,638,643) Unchanged	€ 1,641,872 Land & buildings 2024: € 1,641,872 ▲ 1% vs 2023 (€ 1,619,158) Unchanged	€ 1,590,398 Land & buildings 2025: € 1,590,398 ▼ 3% vs 2024 (€ 1,641,872) Unchanged	▼ 3%
Retained profit	€ 382,001 Retained profit 2022: € 382,001 First fiscal year in the series	€ 383,594 Retained profit 2023: € 383,594 Unchanged (€ 382,001) Favourable step	€ 388,181 Retained profit 2024: € 388,181 ▲ 1% vs 2023 (€ 383,594) Favourable step	€ 392,081 Retained profit 2025: € 392,081 ▲ 1% vs 2024 (€ 388,181) Favourable step	▲ 1%
Dividend	€ 149,500 Dividend 2022: € 149,500 First fiscal year in the series	€ 465,000 Dividend 2023: € 465,000 ▲ 211% vs 2022 (€ 149,500) Unchanged	€ 505,000 Dividend 2024: € 505,000 ▲ 9% vs 2023 (€ 465,000) Unchanged	€ 335,000 Dividend 2025: € 335,000 ▼ 34% vs 2024 (€ 505,000) Unchanged	▼ 34%
Bank debt	€ 1,102,388 Bank debt 2022: € 1,102,388 First fiscal year in the series	€ 1,019,355 Bank debt 2023: € 1,019,355 ▼ 8% vs 2022 (€ 1,102,388) Favourable step	€ 935,574 Bank debt 2024: € 935,574 ▼ 8% vs 2023 (€ 1,019,355) Favourable step	€ 850,987 Bank debt 2025: € 850,987 ▼ 9% vs 2024 (€ 935,574) Favourable step	▼ 9%
Balance sheet total	€ 2,078,878 Balance sheet total 2022: € 2,078,878 First fiscal year in the series	€ 2,343,677 Balance sheet total 2023: € 2,343,677 ▲ 13% vs 2022 (€ 2,078,878) Unchanged	€ 2,802,992 Balance sheet total 2024: € 2,802,992 ▲ 20% vs 2023 (€ 2,343,677) Unchanged	€ 2,548,910 Balance sheet total 2025: € 2,548,910 ▼ 9% vs 2024 (€ 2,802,992) Unchanged	▼ 9%
Employees (FTE)	0.9 Employees (FTE) 2022: 0.9 First fiscal year in the series	0.4 Employees (FTE) 2023: 0.4 ▼ 0.5 vs 2022 (0.9) Unchanged	-	-

Key figures of Apotheek Mannenberg, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Apotheek Mannenberg?

What happened at Apotheek Mannenberg in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 338,900 (▼ 33% vs 2024). filed late Source: NBB ↗
Aug 28, 1997 New establishment in Scherpenheuvel-Zichem. KBO
May 26, 1997 Start of the company according to the CBE. KBO

In short

From € 262,667 profit in 2022 to € 338,900 profit in 2025.

Paid € 5,938 in corporate taxes since 2022.

Best year ever: 2024, with € 509,587 profit.

Paid out € 1.5 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

DAHO 100%

The stake of DAHO comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Apotheek Mannenberg

Behind Apotheek Mannenberg is Daho BV. The shares are held by DAHO (100%).

Directors

According to the 2025 annual accounts

Daho BV

Director · represented by Philippe Dassen

Also active at: APOTHEEK DASSEN

Shareholders

DAHO

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Mannenberg(S) 23

3270 Scherpenheuvel-Zichem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0460.754.255

VAT number

BE 0460.754.255

Registered office

Mannenberg(S) 23, 3270 Scherpenheuvel-Zichem

Names & denominations

Apotheek Mannenberg

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

26 May 1997

Peppol

Active · Active since 1 Jan 2001

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek Mannenberg

Warning lights

Financials

What happened to Apotheek Mannenberg?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions